Cardialarm Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 3

Cardialarm General Information

Description

Developer of a medical device intended to monitor risk of bleeding after catheter interventions. The company's medical device has wireless sensor for centralized monitoring of multiple patients after catheter interventions, enabling doctors to improve the safety and quality in the follow-up of patients after artery catheterization.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • Jon Lilletunsvei 3
  • Technology Park, University of Agder, Campus Grimstad
  • 4879 Grimstad
  • Norway
+47 993 00 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardialarm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 000.00 Completed Generating Revenue
1. Grant 01-Jan-2014 $48.8K Completed Generating Revenue
To view Cardialarm’s complete valuation and funding history, request access »

Cardialarm Executive Team (1)

Name Title Board Seat Contact Info
Carsten Sandholdt Chief Executive Officer & Co-Founder
To view Cardialarm’s complete executive team members history, request access »

Cardialarm Board Members (1)

Name Representing Role Since
Asle Pedersen Cardialarm Board Member 000 0000
To view Cardialarm’s complete board members history, request access »

Cardialarm Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aust-Agder Utviklings og kompetansefond Government 000 0000 000000 0
Coventure (Incubator) Accelerator/Incubator Minority 000 0000 000000 0
The Research Council of Norway Government 000 0000 000000 0
To view Cardialarm’s complete investors history, request access »